Oxolife

Developer of a first-in-class oral drug improving embryo implantation

placeBarcelona, Catalonia, Spain calendar_todayFounded 2013 groups10 employees language oxolife.com

Social engagement

Social engagement: 3.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Inveready.

Investor typeCountShare
Venture capital229%
Accelerator & incubator229%
Other / undisclosed343%

Recent activity

5 Mar 2026
Milestone
cert
27 Feb 2026
Event
4YFN–MWC 2026
18 Feb 2026
Milestone
regulatory
Coming soon